Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ImmunityBio converts from Immunomedics -- Ignore unavailable to you. Want to Upgrade?

To: galt who wrote (994)	5/5/2025 1:08:36 PM
From: jargonweary	1 Recommendation Recommended By erippetoe Read Replies (2) \| Respond to of 1229

I am not adding more at this point because a) I already have too much and, b) I am concerned that the company does have, as you say, an approved drug for one cancer and promising indications for other cancers and yet the stock price is not reflecting the value of that. Why? There is no rush to snap up shares of this company at these depressed levels. Instead it drifts ever lower as some institutions exit and others are clearly uninterested. Why? Perhaps they are loathe to invest in a company with a wacky super majority owner and a seemingly incompetent CEO. Thankfully I can afford to hold on for now but I will not add more and may trim a little bit.